| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | -375.10M | -456.11M | 735.02M | -96.90M | -5.96M | 1.32M |
| Gross Profit | -375.10M | -456.11M | 735.02M | -97.13M | -7.84M | 1.04M |
| EBITDA | 374.22M | -471.30M | 722.72M | -1.77M | 417.18M | -1.96M |
| Net Income | -7.39M | -469.23M | 727.01M | -102.94M | 417.27M | 29.91M |
Balance Sheet | ||||||
| Total Assets | 1.96B | 1.42B | 1.89B | 1.04B | 1.07B | 428.38M |
| Cash, Cash Equivalents and Short-Term Investments | 184.18M | 20.01M | 133.19M | 84.43M | 153.14M | 126.16M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 5.26M | 3.40M | 3.54M | 1.93M | 970.00K | 6.98M |
| Stockholders Equity | 1.96B | 1.41B | 1.88B | 1.04B | 1.07B | 421.39M |
Cash Flow | ||||||
| Free Cash Flow | -11.69M | -13.17M | -6.48M | -5.17M | -9.23M | 509.00K |
| Operating Cash Flow | -11.69M | -13.17M | -6.48M | -5.17M | -9.23M | 509.00K |
| Investing Cash Flow | 0.00 | -100.00M | -66.02M | -132.69M | -193.96M | -5.07M |
| Financing Cash Flow | 169.80M | 0.00 | 121.26M | 69.20M | 230.13M | 124.26M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £4.40B | -42.84 | -3.13% | 14.05% | 41.95% | -140.18% | |
69 Neutral | £5.33B | -24.34 | -4.05% | 8.77% | 57.55% | -54.80% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
58 Neutral | £1.63B | -8.35 | -65.81% | 10.99% | 27.35% | -228.25% | |
55 Neutral | £1.52B | 1.11 | -0.44% | ― | ― | -115.51% | |
46 Neutral | £3.75M | 118.61 | -12.73% | ― | -88.25% | -905.77% |